Lind Global Asset Management V

The Lind Partners is an institutional fund manager that provides growth capital to small- and mid-cap companies across various sectors, with a significant focus on life sciences and biotechnology. Lind Global Asset Management V is one of the firm's primary investment vehicles used to execute structured financing transactions, such as convertible notes and equity-linked investments. The firm supports publicly traded companies on exchanges like the NASDAQ, ASX, and TSX, providing the necessary liquidity for clinical trials and research initiatives. Since its inception in 2011, Lind has completed over 150 direct investments, establishing itself as a key financier for emerging healthcare companies. The firm is headquartered in New York and operates with a global investment mandate.